| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computer Simulation | 14 | 2019 | 681 | 2.130 |
Why?
|
| Software | 14 | 2019 | 756 | 2.060 |
Why?
|
| Models, Genetic | 9 | 2014 | 752 | 1.220 |
Why?
|
| Mouth Neoplasms | 2 | 2024 | 98 | 0.990 |
Why?
|
| Limonins | 1 | 2024 | 3 | 0.890 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2024 | 125 | 0.830 |
Why?
|
| Computational Biology | 5 | 2019 | 872 | 0.790 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2023 | 738 | 0.770 |
Why?
|
| Apoptosis | 3 | 2024 | 1860 | 0.740 |
Why?
|
| Colonic Neoplasms | 2 | 2023 | 265 | 0.740 |
Why?
|
| Workflow | 2 | 2019 | 139 | 0.690 |
Why?
|
| Programming Languages | 2 | 2018 | 19 | 0.640 |
Why?
|
| Genetic Variation | 6 | 2014 | 1566 | 0.630 |
Why?
|
| Stem Cell Transplantation | 2 | 2018 | 236 | 0.620 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2024 | 759 | 0.580 |
Why?
|
| Stem Cells | 4 | 2024 | 713 | 0.570 |
Why?
|
| Genome, Human | 9 | 2015 | 1338 | 0.550 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 1812 | 0.510 |
Why?
|
| Genome-Wide Association Study | 9 | 2015 | 1840 | 0.480 |
Why?
|
| Disease | 4 | 2014 | 125 | 0.430 |
Why?
|
| Biological Evolution | 4 | 2012 | 230 | 0.430 |
Why?
|
| Alleles | 5 | 2015 | 1713 | 0.380 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2017 | 545 | 0.380 |
Why?
|
| Cell Proliferation | 7 | 2024 | 2483 | 0.360 |
Why?
|
| Cell Line, Tumor | 6 | 2024 | 3708 | 0.340 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2015 | 2863 | 0.310 |
Why?
|
| Genetics, Population | 2 | 2010 | 185 | 0.290 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2016 | 934 | 0.290 |
Why?
|
| Algorithms | 3 | 2011 | 1686 | 0.290 |
Why?
|
| User-Computer Interface | 3 | 2019 | 165 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 1413 | 0.270 |
Why?
|
| Signal Transduction | 7 | 2024 | 4693 | 0.260 |
Why?
|
| Adipose Tissue | 3 | 2024 | 495 | 0.250 |
Why?
|
| Cell Cycle | 2 | 2023 | 598 | 0.250 |
Why?
|
| Sequence Analysis, DNA | 4 | 2016 | 1746 | 0.240 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2019 | 244 | 0.240 |
Why?
|
| Internet | 3 | 2018 | 423 | 0.240 |
Why?
|
| Mice, Inbred NOD | 2 | 2023 | 301 | 0.230 |
Why?
|
| Cellular Senescence | 2 | 2024 | 217 | 0.230 |
Why?
|
| Longevity | 2 | 2024 | 176 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2021 | 482 | 0.220 |
Why?
|
| Mice, SCID | 2 | 2023 | 579 | 0.220 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2024 | 46 | 0.220 |
Why?
|
| Humans | 36 | 2024 | 131967 | 0.210 |
Why?
|
| Wound Healing | 2 | 2018 | 477 | 0.210 |
Why?
|
| Sirtuin 1 | 1 | 2024 | 56 | 0.210 |
Why?
|
| Kidney Neoplasms | 2 | 2019 | 453 | 0.210 |
Why?
|
| Models, Statistical | 4 | 2014 | 493 | 0.200 |
Why?
|
| Molecular Sequence Annotation | 2 | 2015 | 152 | 0.200 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2023 | 16 | 0.190 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2024 | 324 | 0.190 |
Why?
|
| Mice | 9 | 2024 | 18504 | 0.190 |
Why?
|
| Genetic Association Studies | 3 | 2015 | 835 | 0.180 |
Why?
|
| Up-Regulation | 1 | 2024 | 832 | 0.180 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2024 | 614 | 0.180 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 520 | 0.180 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 2992 | 0.170 |
Why?
|
| Oxidative Stress | 2 | 2018 | 810 | 0.170 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2021 | 17 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2017 | 3425 | 0.170 |
Why?
|
| Antioxidants | 1 | 2023 | 336 | 0.170 |
Why?
|
| Proteinase Inhibitory Proteins, Secretory | 1 | 2020 | 9 | 0.160 |
Why?
|
| Animals | 11 | 2024 | 34460 | 0.160 |
Why?
|
| Histone Deacetylase 6 | 1 | 2019 | 8 | 0.160 |
Why?
|
| Nicotine | 1 | 2021 | 117 | 0.160 |
Why?
|
| Biocompatible Materials | 1 | 2021 | 122 | 0.160 |
Why?
|
| Hyperalgesia | 1 | 2019 | 26 | 0.160 |
Why?
|
| Epidermis | 1 | 2019 | 64 | 0.150 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2019 | 12 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 3 | 2018 | 421 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 825 | 0.150 |
Why?
|
| Neuralgia | 1 | 2020 | 51 | 0.150 |
Why?
|
| Computing Methodologies | 1 | 2019 | 1 | 0.150 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2018 | 11 | 0.150 |
Why?
|
| Isotope Labeling | 1 | 2019 | 93 | 0.150 |
Why?
|
| Stomatitis, Aphthous | 1 | 2018 | 3 | 0.140 |
Why?
|
| Nitrosative Stress | 1 | 2018 | 3 | 0.140 |
Why?
|
| Eye Neoplasms | 1 | 2018 | 38 | 0.140 |
Why?
|
| Evolution, Molecular | 2 | 2013 | 657 | 0.140 |
Why?
|
| Naphthoquinones | 1 | 2018 | 9 | 0.140 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2018 | 20 | 0.140 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2019 | 137 | 0.140 |
Why?
|
| Cisplatin | 1 | 2019 | 286 | 0.140 |
Why?
|
| Diabetic Angiopathies | 1 | 2018 | 67 | 0.140 |
Why?
|
| Microcirculation | 1 | 2018 | 107 | 0.130 |
Why?
|
| Bandages | 1 | 2018 | 55 | 0.130 |
Why?
|
| Ureteral Neoplasms | 1 | 2017 | 25 | 0.130 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2017 | 34 | 0.130 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2017 | 51 | 0.130 |
Why?
|
| Dermatomyositis | 2 | 2015 | 35 | 0.130 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 363 | 0.130 |
Why?
|
| Hydrogels | 1 | 2018 | 101 | 0.130 |
Why?
|
| Kidney Pelvis | 1 | 2017 | 44 | 0.130 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2017 | 82 | 0.130 |
Why?
|
| Research | 1 | 2019 | 269 | 0.130 |
Why?
|
| Diabetic Retinopathy | 1 | 2018 | 84 | 0.130 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2016 | 6 | 0.130 |
Why?
|
| Urothelium | 1 | 2017 | 61 | 0.130 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 157 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 305 | 0.120 |
Why?
|
| Cell Lineage | 1 | 2018 | 347 | 0.120 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 639 | 0.120 |
Why?
|
| Serine Endopeptidases | 1 | 2017 | 199 | 0.120 |
Why?
|
| Paracrine Communication | 1 | 2016 | 68 | 0.120 |
Why?
|
| Multigene Family | 1 | 2017 | 290 | 0.120 |
Why?
|
| Genotype | 4 | 2014 | 2655 | 0.120 |
Why?
|
| Hyperglycemia | 1 | 2018 | 234 | 0.120 |
Why?
|
| Ureter | 1 | 2017 | 97 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2018 | 363 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2017 | 254 | 0.120 |
Why?
|
| Fibroblasts | 1 | 2020 | 858 | 0.120 |
Why?
|
| Gene Frequency | 3 | 2014 | 750 | 0.120 |
Why?
|
| Precancerous Conditions | 1 | 2018 | 283 | 0.110 |
Why?
|
| Skin | 1 | 2018 | 553 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2016 | 419 | 0.110 |
Why?
|
| Cell Movement | 3 | 2024 | 886 | 0.110 |
Why?
|
| Mutation | 4 | 2018 | 6200 | 0.110 |
Why?
|
| Genomics | 3 | 2017 | 1630 | 0.110 |
Why?
|
| Myositis | 1 | 2015 | 106 | 0.100 |
Why?
|
| Papillomavirus Infections | 1 | 2018 | 388 | 0.100 |
Why?
|
| Quality Control | 1 | 2014 | 118 | 0.100 |
Why?
|
| Virus Integration | 1 | 2014 | 38 | 0.100 |
Why?
|
| Genotyping Techniques | 1 | 2014 | 110 | 0.100 |
Why?
|
| HLA Antigens | 1 | 2015 | 230 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 1 | 2016 | 331 | 0.100 |
Why?
|
| Reproductive Behavior | 1 | 2013 | 7 | 0.100 |
Why?
|
| Biomarkers, Tumor | 3 | 2019 | 1618 | 0.100 |
Why?
|
| Carcinogenesis | 1 | 2016 | 357 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 635 | 0.100 |
Why?
|
| Insulin | 1 | 2018 | 1154 | 0.100 |
Why?
|
| Insulin Resistance | 1 | 2018 | 683 | 0.100 |
Why?
|
| Inheritance Patterns | 1 | 2013 | 130 | 0.100 |
Why?
|
| Linkage Disequilibrium | 3 | 2012 | 318 | 0.090 |
Why?
|
| Protein Kinases | 1 | 2014 | 322 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 345 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2014 | 659 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 427 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 388 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 1131 | 0.090 |
Why?
|
| Fertility | 1 | 2013 | 266 | 0.090 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 275 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 193 | 0.080 |
Why?
|
| DNA Copy Number Variations | 2 | 2017 | 1027 | 0.080 |
Why?
|
| Chromatin | 1 | 2014 | 495 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 2013 | 0.080 |
Why?
|
| Ganglia, Spinal | 2 | 2020 | 64 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 2 | 2014 | 227 | 0.080 |
Why?
|
| Case-Control Studies | 5 | 2018 | 3453 | 0.070 |
Why?
|
| Genetic Markers | 1 | 2010 | 605 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2014 | 2573 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2013 | 1695 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2014 | 895 | 0.060 |
Why?
|
| Base Sequence | 1 | 2011 | 2783 | 0.060 |
Why?
|
| Male | 11 | 2024 | 65357 | 0.060 |
Why?
|
| Emigration and Immigration | 1 | 2006 | 81 | 0.060 |
Why?
|
| Neoplasms | 2 | 2018 | 2965 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2009 | 772 | 0.060 |
Why?
|
| Aging | 2 | 2024 | 1269 | 0.060 |
Why?
|
| Selection, Genetic | 1 | 2006 | 157 | 0.060 |
Why?
|
| Demography | 1 | 2006 | 243 | 0.060 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2009 | 289 | 0.060 |
Why?
|
| Aged | 7 | 2019 | 21279 | 0.060 |
Why?
|
| Computer Graphics | 1 | 2005 | 41 | 0.060 |
Why?
|
| Diploidy | 1 | 2005 | 40 | 0.060 |
Why?
|
| Genetics | 1 | 2005 | 24 | 0.060 |
Why?
|
| Time | 1 | 2005 | 96 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 4684 | 0.060 |
Why?
|
| Cell Shape | 1 | 2024 | 70 | 0.050 |
Why?
|
| beta-Galactosidase | 1 | 2024 | 135 | 0.050 |
Why?
|
| Fluorouracil | 1 | 2004 | 134 | 0.050 |
Why?
|
| Female | 11 | 2019 | 71316 | 0.050 |
Why?
|
| Middle Aged | 7 | 2019 | 28911 | 0.050 |
Why?
|
| Chondroitin Sulfates | 1 | 2023 | 13 | 0.050 |
Why?
|
| Fishes | 1 | 2023 | 33 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2004 | 393 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2004 | 301 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2017 | 418 | 0.050 |
Why?
|
| Cyclophosphamide | 1 | 2004 | 441 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2023 | 143 | 0.040 |
Why?
|
| Obesity | 1 | 2013 | 2392 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2004 | 407 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2020 | 3864 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2023 | 260 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 2014 | 1545 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 1841 | 0.040 |
Why?
|
| Meninges | 1 | 2020 | 22 | 0.040 |
Why?
|
| Sciatic Nerve | 1 | 2020 | 58 | 0.040 |
Why?
|
| Models, Biological | 1 | 2005 | 1396 | 0.040 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2020 | 37 | 0.040 |
Why?
|
| Proteomics | 1 | 2004 | 614 | 0.040 |
Why?
|
| Nerve Fibers | 1 | 2019 | 69 | 0.040 |
Why?
|
| Isotopes | 1 | 2019 | 25 | 0.040 |
Why?
|
| Neoplasms, Adnexal and Skin Appendage | 1 | 2018 | 5 | 0.040 |
Why?
|
| Gene Expression | 1 | 2023 | 1503 | 0.040 |
Why?
|
| Epidermal Cyst | 1 | 2018 | 17 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2011 | 773 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2019 | 241 | 0.040 |
Why?
|
| Leukocytes | 1 | 2020 | 211 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2019 | 280 | 0.040 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2018 | 34 | 0.040 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2018 | 24 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2018 | 127 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2019 | 241 | 0.030 |
Why?
|
| Papillomaviridae | 1 | 2018 | 179 | 0.030 |
Why?
|
| Chronic Pain | 1 | 2020 | 164 | 0.030 |
Why?
|
| Sequence Analysis, Protein | 1 | 2017 | 48 | 0.030 |
Why?
|
| Mutation Rate | 1 | 2017 | 68 | 0.030 |
Why?
|
| Allografts | 1 | 2018 | 215 | 0.030 |
Why?
|
| Adult | 5 | 2018 | 31734 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2018 | 204 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2024 | 1951 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 1357 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 6922 | 0.030 |
Why?
|
| Bacteriophage phi X 174 | 1 | 2016 | 4 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2020 | 531 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2019 | 405 | 0.030 |
Why?
|
| K562 Cells | 1 | 2016 | 97 | 0.030 |
Why?
|
| Phenotype | 2 | 2017 | 4531 | 0.030 |
Why?
|
| Cloud Computing | 1 | 2015 | 13 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 854 | 0.030 |
Why?
|
| Polymyositis | 1 | 2015 | 17 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2016 | 139 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 803 | 0.030 |
Why?
|
| Time Factors | 1 | 2005 | 6285 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 895 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2016 | 314 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2016 | 452 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2017 | 504 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 1406 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 1191 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 234 | 0.030 |
Why?
|
| Recurrence | 1 | 2018 | 1487 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2014 | 146 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 695 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2014 | 200 | 0.030 |
Why?
|
| Sample Size | 1 | 2014 | 86 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 705 | 0.030 |
Why?
|
| Haplotypes | 1 | 2015 | 550 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 1224 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2018 | 3708 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 103 | 0.020 |
Why?
|
| Adolescent | 3 | 2018 | 21008 | 0.020 |
Why?
|
| Probability | 1 | 2013 | 310 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 2148 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 1008 | 0.020 |
Why?
|
| Multifactorial Inheritance | 1 | 2014 | 175 | 0.020 |
Why?
|
| Risk Factors | 2 | 2018 | 10998 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2015 | 466 | 0.020 |
Why?
|
| Transcriptome | 1 | 2019 | 1141 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1916 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 2653 | 0.020 |
Why?
|
| Neurons | 1 | 2019 | 1998 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2009 | 143 | 0.020 |
Why?
|
| Texas | 1 | 2017 | 3629 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 3415 | 0.020 |
Why?
|
| Family Health | 1 | 2009 | 251 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 4961 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 4762 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2017 | 13011 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 62 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2005 | 117 | 0.010 |
Why?
|
| Research Design | 1 | 2009 | 723 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2005 | 147 | 0.010 |
Why?
|
| Melanoma | 1 | 2011 | 921 | 0.010 |
Why?
|
| Mastectomy | 1 | 2004 | 75 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 10108 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2004 | 134 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 216 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 741 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2004 | 303 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2004 | 357 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 17703 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2004 | 1522 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2004 | 1325 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 2123 | 0.010 |
Why?
|